Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Novel promising agent for inflammatory bowel disease and glomerulonephritis therapy

Aug. 16, 2004

Antioxidant compound effective against arteriosclerosis in rodent allograft model

Aug. 9, 2004

Novel CD80 antagonists and their use claimed by Active Biotech

Aug. 9, 2004

Cangene and DynPort seeking approval of VIG products

Aug. 9, 2004

Depletion of B-cells by humanized anti-CD20 antibody in monkeys

Aug. 9, 2004

Potent orally active antiinflammatory agent by Bristol-Myers Squibb

Aug. 5, 2004

Immunostimulatory effects of loxoribine in monocyte-derived DCs

July 30, 2004

Specific oral PI3K inhibitor blocks neutrophil trafficking and activation in vivo

July 27, 2004

Novel cannabinoid CB2 agonists under study at Sanofi-Synthelabo

July 27, 2004

PBI-1393 activates CTLs and induces IL-2 and IFN-gamma synthesis

July 26, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...